Prosecution Insights
Last updated: April 19, 2026

Examiner: IVICH, FERNANDO NMN

Tech Center 1600 • Art Units: 1678

This examiner grants 44% of resolved cases

Performance Statistics

43.5%
Allow Rate
-16.5% vs TC avg
65
Total Applications
+73.5%
Interview Lift
1303
Avg Prosecution Days
Based on 23 resolved cases, 2023–2026

Rejection Statute Breakdown

14.9%
§101 Eligibility
14.7%
§102 Novelty
32.2%
§103 Obviousness
24.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17293678 MOLECULES AND METHODS FOR IMPROVED IMMUNODETECTION OF SMALL MOLECULES SUCH AS HISTAMINE Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17763824 METHODS OF PRODUCING ANTIBODY COMPOSITIONS Final Rejection AMGEN INC.
17439092 COMPOSITIONS AND METHODS FOR DIAGNOSING ACUTE INFECTIOUS PERITONITIS Final Rejection RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
18012798 PROGNOSIS OF CHRONIC INFLAMMATORY DEMYELINATING POLY-NEUROPATHY Non-Final OA Katholieke Universiteit Leuven
17502629 PARTICLE, AFFINITY PARTICLE, TEST REAGENT, AND DETECTION METHOD Final Rejection CANON KABUSHIKI KAISHA
17760692 DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES Final Rejection BRISTOL-MYERS SQUIBB COMPANY
17618869 TARGETS AND METHODS OF DIAGNOSING, MONITORING AND TREATING FRONTOTEMPORAL DEMENTIA Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
17622037 COMPOSITIONS AND METHODS FOR LYME DISEASE Final Rejection The Johns Hopkins University
19111956 IMMUNOASSAY FOR DETECTING BIOLOGICALLY ACTIVE PROTEINS Non-Final OA PHAEOSYNT GMBH
17514016 LINEAR POLYMER AFFINITY AGENT SENSOR FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY AND METHOD USING THE SAME Non-Final OA Regents of the University of Minnesota
17619958 IMMUNE CELL SIGNATURE FOR BACTERIAL SEPSIS Final Rejection The General Hospital Corporation
17637098 SCALED-UP METHODS FOR PURIFYING ANTIBODIES Final Rejection Yeda Research and Development Co. Ltd.
17614563 ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF Final Rejection YEDA RESEARCH AND DEVELOPMENT CO. LTD.
17770447 METHOD FOR SEPARATING AND DETECTING EXOSOMES, AND KIT FOR SEPARATION AND DETECTION THEREOF Non-Final OA KEIO UNIVERSITY
17610044 MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS Non-Final OA QUEST DIAGNOSTICS INVESTMENTS LLC
17575137 SUBSTANCE P AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS Final Rejection Roche Diagnostics Operations, Inc.
17575120 S100A9 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS Final Rejection Roche Diagnostics Operations, Inc.
17728292 MULTI-PLEX ASSAY PLATES AND METHODS OF MAKING Non-Final OA Meso Scale Technologies, LLC.
17266029 METHOD FOR CULTURING CANCER TISSUE OR TISSUE ANALOGOUS TO CANCER TISSUE Final Rejection Chugai Seiyaku Kabushiki Kaisha
17615202 EXPANDED T CELL ASSAY Final Rejection ModernaTX, Inc.
17918686 METHOD FOR PREDICTING THE RETURN TO FUNCTIONAL AUTONOMY IN A SUBJECT SUFFERING FROM AN ACUTE EVENT Final Rejection INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
17598015 MAGNETIC RESPONSIVE PARTICLE AND IMMUNOASSAY METHOD USING SAME, REAGENT FOR IMMUNOASSAY Non-Final OA SEKISUI MEDICAL CO., LTD.
17765383 XBP1 ISOFORM MULTIPLEX ASSAY Final Rejection Randox Teoranta
17618837 SYNTHROCYTE: ERYTHROCYTE-MIMICKING REAGENT AND FAST METHODS FOR PATHOGEN CHARACTERIZATION AND SEROLOGY TESTING Final Rejection FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
17638501 KIT AND METHOD FOR CAPTURING A MOLECULE WITH MAGNETIC MEANS Non-Final OA INSTITUT POLYTECHNIQUE DE GRENOBLE
17927648 MACHINE READABLE DIAGNOSTIC TESTS AND METHODS AND APPARATUS TO MAKE AND/OR PROCESS THE SAME Final Rejection Abbott Rapid Diagnostics International Unlimited Company
17911959 DEVICES AND METHODS FOR TREATING ISCHAEMIA AND ACUTE RESPIRATORY DISTRESS SYNDROMES Non-Final OA Galaxy CCRO, Inc.
17636755 SYSTEMS AND METHODS FOR MENSTRUAL CYCLE TESTING Non-Final OA MFB Fertility, Inc.
17795513 DIAGNOSTIC REAGENT FOR QUANTITATIVE DETERMINATION OF PROCALCITONIN IN A SAMPLE Final Rejection DiaSys Diagnostic Systems GmbH
17747590 METHOD FOR MEASURING BETA-1,3-1,6-GLUCAN Final Rejection Tokyo University of Pharmacy & Life Sciences

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month